|
Featured Articles
|
|
Advancing The Development Of Dietary Supplements And Biologics
By Mike Kuehne, ACSYS, Inc.
Organizations that consistently develop and launch new products efficiently in an environment of increasing regulatory scrutiny successfully manage regulatory risk. Organizational regulatory risk management capabilities may become a competitive advantage for all development stages.
|
|
|
Rethink Transdermal
By Anne M. Roush, 3M Drug Delivery Systems
In the face of a significant patent cliff, many companies in the pharmaceutical industry are seeking new ways to protect their brands as long as possible, and reformulation presents one of the most obvious ways to do this.
|
|
|
|
|
|
|